Novartis takes Digger DTC character on the road

Share this article:
Novartis has taken Digger the Dermatophyte, its animated character from DTC television ads for Lamisil, on the road as part of a national bus tour and education campaign.
The "Hit the Road Digger!" campaign made its first stop in Philadelphia today.
The bus tour will take place through August and visit a total of 23 cities, making stops at major sporting events including the Preakness Stakes horse racing event, the Indianapolis 500 auto race and various marathons and state fairs.
Board certified podiatrists will be on hand at each stop to help educate people about proper treatment of conditions such as nail fungal infection and to provide free foot health screenings, Novartis said.
Visitors will also receive free educational materials and have the opportunity to have their photo taken with Digger.
"The character of Digger resonates well with consumers. With the Hit the Road Digger tour we are hoping to create a surround sound effect by reaching consumers not only through DTC ads but at events where they are in large groups," said Kate O'Connor a Novartis spokeswoman.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.